Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2014, Article ID 434987, 4 pages
http://dx.doi.org/10.1155/2014/434987
Case Report

First Description of KPC-2-Producing Klebsiella oxytoca Isolated from a Pediatric Patient with Nosocomial Pneumonia in Venezuela

Laboratorio de Microbiología Molecular, Departamento de Microbiología y Parasitología, Facultad de Farmacia y Bioanálisis, Universidad de Los Andes, Mérida 5101, Venezuela

Received 31 August 2014; Accepted 11 October 2014; Published 22 October 2014

Academic Editor: Larry M. Bush

Copyright © 2014 Indira Labrador and María Araque. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Nordmann, G. Cuzon, and T. Naas, “The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria,” The Lancet Infectious Diseases, vol. 9, no. 4, pp. 228–236, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Sacha, A. Ostas, J. Jaworowska et al., “The KPC type β-lactamases: new enzymes that confer resistance to carbapenems in Gram-negative bacilli,” Folia Histochemica et Cytobiologica, vol. 47, no. 4, pp. 537–543, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Yigit, A. M. Queenan, G. J. Anderson et al., “Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae,” Antimicrobial Agents and Chemotherapy, vol. 45, no. 4, pp. 1151–1161, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. T. D. Gootz, M. K. Lescoe, F. Dib-Hajj et al., “Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City Hospital,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 5, pp. 1998–2004, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. R. S. Arnold, K. A. Thom, S. Sharma, M. Phillips, J. K. Johnson, and D. J. Morgan, “Emergence of Klebsiella pneumoniae carbapenemase (KPC)-producing bacteri,” South Medical Journal, vol. 104, no. 1, pp. 40–45, 2011. View at Google Scholar
  6. M. V. Villegas, K. Lolans, A. Correa et al., “First detection of the plasmid-mediated class a carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 8, pp. 2880–2882, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Yigit, A. M. Queenan, J. K. Rasheed et al., “Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem -hydrolyzing β- lactamase KPC-2,” Antimicrobial Agents and Chemotherapy, vol. 47, no. 12, pp. 3881–3889, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Li, J. Y. Sun, Q. Z. Liu, L. Z. Han, X.-H. Huang, and Y.-X. Ni, “First report of Klebsiella oxytoca strain coproducing KPC-2 and IMP-8 carbapenemases,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 6, pp. 2937–2941, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. A. C. S. Almeida, F. L. S. Cavalcanti, W. M. B. Martins et al., “First description of kpc-2-producing klebsiella oxytoca in brazil,” Antimicrobial Agents and Chemotherapy, vol. 57, no. 8, pp. 4077–4078, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Hoenigl, T. Valentin, G. Zarfel et al., “Nosocomial outbreak of klebsiella pneumoniae carbapenemase-producing klebsiella oxytoca in Austria,” Antimicrobial Agents and Chemotherapy, vol. 56, no. 4, pp. 2158–2161, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. Clinical and Laboratory Standards Institute, “Performance Standards for Antimicrobial Susceptibility Test,” 24th informational supplement. CLSI document M100-S24. Wayne, Pa, USA, 2014.
  12. Clinical and Laboratory Standards Institute, Performance Standards for Antimicrobial Susceptibility Test: 24th Informational Supplement. CLSI Table 3C Screening and Confirmatory Tests for Suspected Carbapenemase Production in Enterobacteriaceae Using Interpretive Criteria in M100-S20, Clinical and Laboratory Standards Institute, Wayne, Pa, USA, 2014.
  13. A. Tsakris, A. Poulou, K. Themeli-Digalaki et al., “Use of boronic acid disk tests to detect extended-spectrum β-lactamases in clinical isolates of KPC carbapenemase-possessing Enterobacteriaceae,” Journal of Clinical Microbiology, vol. 47, no. 11, pp. 3420–3426, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. H. C. Bimboim and J. Doly, “A rapid alkaline extraction procedure for screening recombinant plasmid DNA,” Nucleic Acids Research, vol. 7, no. 6, pp. 1513–1523, 1979. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Ma, F.-Y. Chang, C.-P. Fung et al., “Variety of TEM-, SHV-, and CTX-M-type β-lactamases present in recent clinical isolates of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae from Taiwan,” Microbial Drug Resistance, vol. 11, no. 1, pp. 31–39, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. P. A. Bradford, S. Bratu, C. Urban et al., “Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City,” Clinical Infectious Diseases, vol. 39, no. 1, pp. 55–60, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Araque, B. Nieves, L. Lauretti, and G. M. Rossolini, “Molecular basis of extended-spectrum β-lactamase production in nosocomial isolates of Klebsiella pneumoniae from Merida, Venezuela,” International Journal of Antimicrobial Agents, vol. 15, no. 1, pp. 37–42, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Araque and I. Rivera, “Simultaneous presence of blaTEM and blaSHV genes on a large conjugative plasmid carried by extended-spectrum-lactamase -producing Klebsiella pneumoniae,” The American Journal of the Medical Sciences, vol. 327, no. 3, pp. 118–122, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Millán, D. Castro, B. Ghiglione, G. Gutkind, and M. Araque, “IS CR1 asociado a genes blaCTX-M-1 y blaCTX-M-2 en plásmidos IncN e IncFIIA aislados en Klebsiella pneumoniae de origen nosocomial en Mérida, Venezuela,” Biomédica, vol. 33, no. 2, pp. 268–275, 2013. View at Publisher · View at Google Scholar
  20. G. C. Lee and D. S. Burgess, “Treatment of Klebsiella Pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports,” Annals of Clinical Microbiology and Antimicrobials, vol. 11, article 32, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Du, Y. Fu, and Y. Yu, “Tigecycline treatment of infection caused by KPC-producing Escherichia coli in a pediatric patient,” Annals of Clinical Microbiology and Antimicrobials, vol. 12, no. 1, article 19, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Zhang, L. Yang, J. C. Jia, H. W. Zhou, and G.-X. Chen, “High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression,” Journal of Medical Microbiology, vol. 57, no. 3, pp. 332–337, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Luque, P. Bohórquez, and D. Marcano, “Diseminación de enterobacterias productoras de carbapenemasas tipo KPC en Venezuela,” Boletín Venezolano de Infectología, vol. 23, no. 1, pp. 13–19, 2012. View at Google Scholar